CIK: 1591312 - Address: C/O Xencor, Inc., 465 N Halstead Street, Suite 200, Pasadena, CA 91107
24 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret1140113305910040
S%wins5075000021

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/14/24 18:38
11/13/24
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOM.d5315.69031353D
11/14/24 18:38
11/13/24
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-8124.020-3-1353D
3/12/24 16:03
3/11/24
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS-6423.500-3-1352D
3/7/24 16:01
3/5/24
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-29423.430-13-3355D
12/29/23 16:24
12/29/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOM.d71811.0506526313D
12/29/23 16:24
12/29/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-94220.930-45-13313D
6/22/23 08:33
6/21/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOM.d3234.2507635292D
6/22/23 08:33
6/21/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-87726.190-33-10292D
3/13/23 19:40
3/9/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS-7829.880-3-1250D
3/8/23 19:54
3/6/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS-18331.420-6-2252D
3/6/23 21:34
3/3/23
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-9031.540-3-1258D
3/10/22 17:00
3/9/22
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS-7229.000-2-1208D
3/7/22 17:00
3/3/22
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-8829.900-3-1210D
3/3/21 20:01
3/3/21
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS-12844.880-3-2141D
6/15/18 20:11
6/15/18
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-2,02640.510-50-13343D
6/15/18 20:11
6/15/18
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOM.d2134.2505017343D
9/1/16 16:25
8/30/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS-87221.806-40-10341D10027804513-3-3-2-50142022
8/18/16 17:00
8/16/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOM.d680.5900611543381D12019957417171-31-1142410
8/18/16 17:00
8/16/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-1,01222.066-46-11381D12019957417171-31-1142410
5/25/16 16:24
5/24/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOM.d680.5900211558312D65-23-518-102013606661100
5/25/16 16:24
5/24/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-59713.002-46-13312D65-23-518-102013606661100
3/21/16 16:07
3/17/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOM.d680.5900311589243D-9-25-38-22129-724-31614102100
3/21/16 16:07
3/17/16
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOS.d-50611.023-46-16243D-9-25-38-22129-724-31614102100
3/16/15 15:02
3/12/15
XNCRXencor IncDEHealthDrugPharmaceutical PreparationsDahiyat Bassil ICADOP,CEOM.d1470.59006250167D63528-4-5-9-241083313-12

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact